Articles tagged with Stem Cell Research
Three UCI projects focus on mitochondria, spinal cord injuries and genetic manipulation of human embryonic stem cells. Researchers aim to develop therapies and treatments for degenerative diseases and cancers.
The University of Wisconsin is conducting a clinical trial using adult stem cells to treat severe coronary artery disease. The study aims to investigate the efficacy and safety of blood-derived selected stem cells in improving symptoms and clinical outcomes in patients with chronic myocardial ischemia.
The study identifies centrosome asymmetry as a key regulator of asymmetric stem cell division, ensuring the correct differential identity of resulting cells. This complex behavior is precisely regulated, coinciding with the orientation in which the stem cell must divide to guarantee asymmetry.
Mayo Clinic researchers successfully transplanted cardiac preprogrammed embryonic stem cells into diseased hearts, regenerating infarcted heart muscle without tumor formation. The study establishes a tumor-resistant approach to growing new heart tissue from an embryonic stem cell source.
Researchers have developed a technique to encourage survival and growth of adult stem cells, found in many tissues, which hold great promise for treating injuries and some diseases. The study's findings suggest that by manipulating the environment surrounding the cells, certain growth factors can protect them from pro-death signals.
Researchers identified Jumonji proteins essential for cellular differentiation, inactivating genes critical to embryogenesis. The study uses C. elegans and mouse embryonic stem cells, with potential applications in cancer treatment using inhibitors.
Researchers successfully produced neurons in vitro using stem cells from adult human skin, a breakthrough that could lead to revolutionary advances in treating neurodegenerative diseases like Parkinson's. The method used involves extracting neuron precursor cells from skin samples and cultivating them in an appropriate environment.
UCLA scientists have been awarded $4 million in seed grants to fund innovative research projects on human embryonic stem cells. The Institute for Stem Cell Biology and Medicine at UCLA will utilize these funds to explore various aspects of human embryonic development, immune response, and cell differentiation.
Researchers at Stanford University School of Medicine are exploring stem cell transplants as a potential treatment for hearing loss. The goal is to develop a cure for deafness, with a focus on drug therapy and stem cell transplantation into the inner ear.
Researchers at USC's Keck School of Medicine and Childrens Hospital Los Angeles will explore the therapeutic potential of stem cells in retinal degeneration and Ewing's sarcoma. The $3.4 million grant aims to accelerate discoveries in stem cell research.
Six UCI scientists received CIRM SEED grants to study human embryonic stem cells in various diseases, including muscular dystrophy and mitochondrial dysfunction. The research aims to develop therapies for patients suffering from these conditions and improve the therapeutic potential of human embryonic stem cells.
The California Institute for Regenerative Medicine (CIRM) has awarded $5.9 million to the Burnham Institute for Medical Research to launch innovative stem cell research projects. The funding will support studies in heart disease, Parkinson's, cancer, and neural development, among other areas.
Researchers at the University of Pennsylvania have successfully used uniparental embryonic stem cells to repopulate a damaged organ with healthy cells in adult mice. This breakthrough could provide a less controversial alternative to traditional embryonic stem cell therapy, and may offer therapeutic benefits for both males and females.
Stem cells in fruit fly gut use Notch signaling to replenish specific cell types, with Delta protein controlling cell fate and division. This finding transforms basic understanding of stem cells and could prove valuable in cancer research.
Researchers at Rockefeller University have cloned healthy mice from adult stem cells, a breakthrough that could lead to new therapies and treatments. The successful cloning rate was 1.6% when using female skin stem cells, but higher when using male stem cells, opening up potential for future human applications.
Researchers found lower transplant rates in African-Americans compared to Caucasians, even when using self-donated or relative-donated stem cells. The discrepancy may be attributed to various factors, including differences in insurance coverage, cultural attitudes, and physician biases.
Duke University researchers developed a three-dimensional fabric scaffold for cartilage repair using patient stem cells. The new technology could treat larger areas of cartilage damage and provide more effective results than current therapies.
Researchers at the University of Minnesota successfully used adult stem cells to replace the immune system and bone marrow of mice, offering a promising new therapy for people in the future. The study replicated previous findings and demonstrated that multipotent adult progenitor cells (MAPCs) can give rise to blood cells.
A new study has identified a gene that regulates adult stem cell growth, which could lead to increased doses of chemotherapy and faster recovery times for cancer patients. The discovery also opens up possibilities for treating other diseases such as liver disease and diabetes.
Researchers discovered that stem cell activity decreases with age due to reduced division, not a lack of starting material. The finding offers new avenues for combating cognitive decline and neurodegenerative disorders like Alzheimer's disease.
Researchers found that an enzyme called aurora-A is required to coordinate protein position within neural stem cells, and its absence leads to overproduction of new neuroblasts and tumors. In humans, this enzyme may prevent abnormal tumor growth by maintaining a steady population of stem cells.
Researchers found that mice with severely damaged brains showed substantial mending within weeks after losing specific genes. The repair was attributed to neural stem cell 'escapees' that retained or restored the gene activity, enabling regenerative potential.
A Pittsburgh-based research team has created an innovative ink-jet system to print bio-inks that direct muscle-derived stem cells to differentiate into both muscle and bone cells. This technology could revolutionize the design of replacement body tissues, benefiting millions of people with damaged tissues due to various conditions.
Researchers at St. Jude Children's Research Hospital found that harvesting aggressive stem cells from donated bone marrow can reduce the time it takes for a child's immune system to rebuild after a bone marrow transplant. This could lead to lower risk of fatal virus infections and improved long-term outcomes.
A simpler, cheaper method for cell fusion has been developed by Chang Lu at Purdue University, enabling researchers to fuse cells with greater control and precision. The new technology uses constant DC voltage and could lead to breakthroughs in stem cell research, disease antibody production, and cloning.
A sugar molecule called SSEA-4 has been found on the surface of adult stem cells in bone marrow, which give rise to fat, cartilage, and bone. This discovery may help isolate and purify these cells for use in therapies aimed at bone healing, tendon repair, and cartilage regeneration.
A study published in Nature demonstrated TB4's ability to regenerate coronary vessels in mice, a finding that could lead to new treatments for human heart disease. TB4 may prevent loss of heart muscle cells and restore blood flow, providing a much-needed treatment modality.
Researchers at Columbia University Medical Center present several studies on cardiovascular diseases, including the molecular roots of atrial fibrillation, genes influencing heart transplant rejection, and the cost of end-stage heart failure. Additionally, they explore the potential of stem cells to repair cardiac damage in patients wi...
Researchers at Johns Hopkins Medicine have successfully grown and implanted adult pig stem cells to repair damaged heart tissue after a lab-induced heart attack. The study demonstrates proof of principle for using cardiac stem cell therapy to regenerate infarcted heart muscle and restore heart cell function.
Researchers discovered that stem cells communicate with niche cells through the Notch pathway, leading to increased niche cell production and larger stem cell populations. This two-way dialogue enables stem cells to maintain an active niche, which is essential for their self-renewal and differentiation into specialized cells.
Researchers at Scripps Research Institute have discovered a synthetic compound called pluripotin that maintains the youthfulness of stem cells without the need for feeder cells. This breakthrough accelerates stem cell research and holds promise for developing new therapies for diseases like cancer and Parkinson's.
Researchers at the University of Pittsburgh are exploring the use of fat-derived stem cells for breast reconstruction, aiming to create durable replacement soft tissue. The study, led by Dr. J. Peter Rubin, may provide a safer option for breast cancer patients, avoiding invasive surgery and potential risks.
Researchers at UC Berkeley used mechanical stretching to guide bone marrow stem cells towards becoming smooth muscle tissue, similar to that found in blood vessels. The study suggests that a combination of chemical and mechanical factors will be needed to achieve efficient cell differentiation.
Researchers at Duke University Medical Center have found that cancer stem cells in brain tumors activate a 'repair switch' that enables them to continue growing unchecked after radiation treatment. A method to block this process has been identified, offering hope for developing therapies to overcome radiation resistance.
Researchers have identified Tcf3, a transcription factor that regulates skin stem cells, as a key repressor switch. Activating this gene can prevent skin stem cells from maturing into adult skin cells, potentially providing insights for lab-grown stem cells and therapies.
Researchers have successfully cloned mice using fully differentiated blood cells, disproving the need for adult stem cells in the process. The study found that these cells were more efficient than stem cells or progenitor cells, paving the way for new approaches to animal cloning.
Researchers at Duke University Medical Center identified the SOX2 gene as crucial for taste bud development, revealing its role in stem cell transformation and cellular differentiation. The findings may lead to a better understanding of developmental disorders and provide insights into how stem cells operate in adults.
The University of Rochester Medical Center is establishing a leading program in Cancer Stem Cell Research to discover cures for cancer. By studying the 'master cells' of this deadly disease, scientists aim to find underlying causes and develop therapies to target cancer stem cells.
Researchers at UW-Madison have developed DNA-coated stents that release gene-based therapy to prevent restenosis, a common problem with metal stents. Additionally, they've created microwell arrays to grow undifferentiated human embryonic stem cells with defined sizes and shapes.
Researchers from ISREC discovered that the Nodal protein, involved in embryonic development, maintains stem cells while also providing cues for their differentiation. This understanding is crucial for coaxing stem cells to grow into specific tissues outside the body and may hold the key to controlling cancerous stem cell behavior.
Researchers at University of Pennsylvania discovered that adult stem cells depend on physical microenvironment clues to differentiate into various tissue types. By manipulating the firmness of the gel, scientists can guide stem cells towards specific fates.
Researchers have successfully induced differentiated adult cells to behave like embryonic stem cells using only four factors. This breakthrough enables the creation of pluripotent cells directly from a patient's own cells, potentially revolutionizing the treatment of diseases such as Parkinson's disease and diabetes.
Researchers have successfully induced differentiated adult cells to behave like embryonic stem cells using only four factors. The discovery could revolutionize the treatment of diseases such as Parkinson's and diabetes by providing a direct source of pluripotent cells from patients' own cells.
Researchers at UCLA compared neural stem cells grown in the lab to those derived from donated fetal tissue and found the former expressed lower levels of a metabolic gene called CPT 1A. This abnormality may impact the effectiveness of these stem cells in treating diseases such as Parkinson's and Alzheimer's.
The Tri-Institutional Stem Cell Initiative has approved $6.7 million in funding for 17 stem cell research projects, exploring basic biology and therapeutic potential of human and model organism-derived stem cells. The grants support collaborative research across three institutions, including Memorial Sloan-Kettering Cancer Center.
Using minimally invasive robotic surgery, researchers successfully transplanted stem cells into damaged pig hearts, showing improved function and cell engraftment. The technique offers several benefits for patients with heart failure, including reduced risk and less time under anesthesia.
Researchers from University of California, Irvine, found that transplanted human embryonic stem cells do not cause harm and can be used to treat acute spinal cord injuries. The study confirmed previous findings that replacing a cell type lost after injury improves outcomes in rodents.
Researchers at Dana-Farber Cancer Institute isolated leukemia stem cells from a mouse model, showing they are surprisingly different from normal blood stem cells. This finding may lead to the development of drugs that selectively target these cells, which could improve treatment outcomes for leukemia patients.
University of Illinois researchers found unexpected two-way communication between blood stem cells and T cells, changing their fate. This loop may lead to a strong immune response, increasing the risk of graft-versus-host disease or rejection.
Scientists have successfully produced sperm from embryonic stem cells, paving the way for new treatments for male infertility. The breakthrough, led by Karim Nayernia at Newcastle University, used mice and produced seven babies, six of which lived to adulthood.
Sue J. Gross and William H. Gross have made a $10 million gift to UC Irvine to support stem cell research, enabling scientists to collaborate and advance the field. The donation will facilitate research efforts and build a proposed Stem Cell Research Center building.
Dental stem cells have been characterized for their potential to differentiate into various tooth tissue types. The study aims to define the molecular and differentiation profiles of these cells, enabling ongoing tooth tissue engineering efforts.
Researchers found that marrow stem cells have receptors that detect bacteria and viruses, triggering a response to fight pathogens. This discovery could lead to new treatments for leukemias and autoimmune diseases like lupus and rheumatoid arthritis.
Egg donation for stem cell research is a contentious issue, with concerns over informed consent, health risks, and distributive justice. Researchers have developed guidelines to balance bioethical principles and reduce risks for donors, exploring alternative sources of eggs and incentivizing participation.
Researchers have identified a signal transduction process regulating stem-cell division, which could lead to drugs stimulating endogenous cell production. The discovery may help treat conditions such as stroke and Parkinson's by promoting the formation of new nerve cells.
Researchers at SickKids have discovered that stem cells found in adult skin can generate Schwann cells that can myelinate demyelinated axons and provide a growth environment for injured central nervous system axons. This breakthrough has the potential to treat nerve injuries, demyelination disorders such as multiple sclerosis, and spin...
Researchers used RNA interference to silence genes regulating muscle cell formation and osteogenic signals. The study found that turning off these inhibitors increased the cells' bone-forming potential, with 60% of mice developing radiologically detectable bone after implantation.
A clinical trial found that injecting stem cells from a woman's own muscle may effectively treat urinary incontinence. Five of seven patients reported significant improvements in bladder control and quality of life with no serious adverse effects. A follow-up study is planned to determine the optimal dose for effective treatment.
The center will support development of new therapies for heart, cancer, and neurological disorders through early patient clinical trials. Non-embryonic stem cell research has been exceptionally strong in Ohio, bringing together academic investigators and industry partners to accelerate moving cutting-edge research into the clinic.
Researchers have discovered that frog proteins can rescue mouse embryonic stem cells from dividing without limit, highlighting an ancient mechanism that may hold the key to understanding human disease. The study also shows that mammals have adopted this function from amphibians, suggesting a long history of stem cell regulation.